摘要
目的:观察舒普深治疗肺部感染的疗效及安全性。方法:肺部感染128例随机分为两组:舒普深组64例,静滴1.0~2.0g,bid;头孢三嗪组64例,静滴1.0~2.0g,bid,两组均治疗1~2周。结果:舒普深组及头孢三嗪组有效率分别为93.7%及89.1%,细菌清除率分别为89.7%及83.8%,不良反应发生率分别为6.3%及8.1%。经统计学处理均无显著性差异(P>0.05)。
OBJECTIVE:To evaluate the efficacy and safety of sulperazon in comparison with ceftriaxone in treatment of lung infections.METHODS:128 patients with lung infections were equally divided to receive sulperazon infusion or ceftriaxone infusion in a regimen of 1.0~ 2.0g ,bid for 1~2 weeks.RESULTS:The effective rate,bacterial clearance rate,and ADRs incidence rate of both agents are similar without statistically significant difference( P >0.05).CONCLUSION:From results of this study it can be concluded that sulperazon is an effective and safe drug for treatment of lung infection.
出处
《中国新药杂志》
CAS
CSCD
1999年第4期250-252,共3页
Chinese Journal of New Drugs